Sibel Suzen

Ankara, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Novel 3,3'-diindolylmethane derivatives as multi-pathway modulators: targeting estrogen-dependent and independent breast cancer carcinogenesis.

Novel 3,3'-diindolylmethane derivatives as multi-pathway modulators: targeting estrogen-dependent and independent breast cancer carcinogenesis.

Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences

Published: April 02, 2026

Modulation of Nrf2 and Mitochondrial Function: Pharmacological Implications.

Modulation of Nrf2 and Mitochondrial Function: Pharmacological Implications.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 12, 2025

Modulating Nrf2 to control lipid peroxidation and ferroptosis: implications for cancer management.

Modulating Nrf2 to control lipid peroxidation and ferroptosis: implications for cancer management.

Journal: Frontiers in oncology

Published: September 08, 2025

In Vitro Evaluation of Endocrine-Related Adverse Effects of 5-Fluoroindole Derived Melatonin Analogues with Antioxidant Activity.

In Vitro Evaluation of Endocrine-Related Adverse Effects of 5-Fluoroindole Derived Melatonin Analogues with Antioxidant Activity.

Journal: Chemistry & biodiversity

Published: August 20, 2024

Enzyme inhibitory potential of some indole Schiff bases on acetylcholinesterase and human carbonic anhydrase isoforms I and II enzymes: an in vitro and molecular docking study.

Enzyme inhibitory potential of some indole Schiff bases on acetylcholinesterase and human carbonic anhydrase isoforms I and II enzymes: an in vitro and molecular docking study.

Journal: Journal of biomolecular structure & dynamics

Published: October 20, 2023

A Review of the Potential of Nuclear Factor [Erythroid-Derived 2]-like 2 Activation in Autoimmune Diseases.

A Review of the Potential of Nuclear Factor [Erythroid-Derived 2]-like 2 Activation in Autoimmune Diseases.

Journal: Brain sciences

Published: July 16, 2023

Melatonin as mitochondria-targeted drug.

Melatonin as mitochondria-targeted drug.

Journal: Advances in protein chemistry and structural biology

Published: July 12, 2023

A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies.

A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 04, 2022

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.

Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry

Published: May 12, 2021

Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer.

Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer.

Journal: Molecules (Basel, Switzerland)

Published: February 12, 2021

Short overview on the relevance of microRNA-reactive oxygen species (ROS) interactions and lipid peroxidation for modulation of oxidative stress-mediated signalling pathways in cancer treatment.

Short overview on the relevance of microRNA-reactive oxygen species (ROS) interactions and lipid peroxidation for modulation of oxidative stress-mediated signalling pathways in cancer treatment.

Journal: The Journal of pharmacy and pharmacology

Published: November 27, 2020

Novel effective antibacterial small-molecules against Staphylococcus and Enterococcus strains.

Novel effective antibacterial small-molecules against Staphylococcus and Enterococcus strains.

Journal: Future medicinal chemistry

Published: June 10, 2020

Showing 1-12 of 48

Last Updated: 09/26/2026